Conversion AgreementConversion Agreement • January 25th, 2022 • Q BioMed Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 25th, 2022 Company Industry JurisdictionThis Conversion Agreement (this “Agreement”) is made and entered into as of January 21, 2022, by and between Q Biomed Inc., a Nevada corporation (the “Company”), and YA II PN, Ltd. (the “Holder”), holder of the Company’s Convertible Debentures (the “Debentures”).